INSPIRE for Shortness of Breath in Lung Cancer
This study is testing a new program called INSPIRE to help people with lung cancer manage shortness of breath (dyspnea). Dyspnea is a common and difficult symptom for many lung cancer patients. Current treatments often don't provide enough relief, so researchers are looking for better ways to help. INSPIRE is a personalized program that combines different types of support, including behavioral and cognitive-behavioral techniques. This first phase of the study will involve about 10 participants and aims to get feedback from patients and doctors to make the INSPIRE program even better. The main goal is to see what patients think of the program after 4 months.
- Study design
- This is an interventional study with a planned enrollment of 10 participants. It is an open pilot study, meaning all participants will receive the INSPIRE intervention.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Patient feedback will be measured at 4 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Stepped Intervention for Coping With Dyspnea in Patients With Lung Cancer-Phase A (Open Pilot)
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Qualitative patient feedback4 months
The investigators will collect the qualitative experience of study patients obtained through exit interviews and feedback.